Indication
Aging Frailty
2 clinical trials
3 products
Clinical trial
Effects of Intravenous Delivery of Lomecel-B (Formerly Allogenic Longeveron Human Mesenchymal Stem Cells (LMSCs)) on VaccinE-Specific Antibody Responses in Subjects With Aging FrailtyStatus: Completed, Estimated PCD: 2021-09-01
Product
Fluzone High DoseClinical trial
An Open-Label Single-Arm Phase I/IIa Study to Evaluate the Safety of Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte in Patients With Aging FrailtyStatus: Recruiting, Estimated PCD: 2024-11-28
Product
StromaForte